https://www.aafp.org/pubs/afp/issues/2004/0301/p1223.html
Efalizumab Effective in Treatment of Plaque Psoriasis | AAFP
in treatmentplaque psoriasiseffectiveaafp
https://adisinsight.springer.com/drugsafety/801122682?error=cookies_not_supported&code=0ab0e4e2-a629-4070-89ac-cae287f0df9d
Efalizumab - AdisInsight
A 54-year-old man with chronic psoriasis developed fever of unknown origin (FUO) and bilateral sensorineural hearing loss during treatment with efalizumab.Three
adisinsight
https://pubmed.ncbi.nlm.nih.gov/17668531/
Case reports: efalizumab-associated lymphoproliferative disease
Efalizumab is an immunosuppressive agent that has been approved for the treatment of psoriasis. There has been mounting evidence that efalizumab may be...
case reportsassociateddisease